SKB BIO-B (06990) subscribed to structured deposits.

SKB BIO-B (06990) announced that on January 20, 2025, the company entered into an agreement with the Bank Of Chengdu...

Zhitong FinanceMar 20 10:39 ET

Express News | Sichuan Kelun-Biotech Biopharmaceutical - Co to Subscribe for 2 Structured Deposits From Bocd Each in Principal Amount of RMB50 Mln

ReutersMar 20 10:36 ET

Goldman Sachs: Assigned a "Buy" rating to SKB BIO-B (06990) with a Target Price of HK$239.14.

The bank expects SKB264 (TROP2ADC) to become a key driving force for the future growth of Kelun-Botai.

Zhitong FinanceMar 13 22:13 ET

Private Companies Invested in Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990) Copped the Brunt of Last Week's HK$3.1b Market Cap Decline

Simply Wall StMar 13 21:11 ET

SKB BIO-B (06990.HK) plans to hold a Board of Directors meeting on March 24 to approve the annual performance.

Gelonghui, March 12 - SKB BIO-B (06990.HK) announced that the Board of Directors has scheduled a board meeting on Monday, March 24, 2025, to consider and approve the company's and its subsidiaries' annual performance for the year ending December 31, 2024, and its release, as well as to address other matters.

Gelonghui FinanceMar 12 05:05 ET

SKB BIO-B: NOTICE OF BOARD MEETING

HKEXMar 12 05:01 ET · Announcements